Scholarlink

<p>Chronic respiratory diseases cause substantial global morbidity and mortality, yet the shared genetic architecture of pulmonary-function traits, exposure-related phenotypes, and cardiometabolic traits remains incompletely characterised. We applied genomic structural equation modelling to GWAS summary statistics for four pulmonary-function traits, lifetime smoking index, ambient PM2.5 exposure, and arterial oxygen tension to model their shared genetic covariance (mvLung). The mvLung GWAS identified 2,156 loci, including 376 not significant in the individual input GWASs. EFEMP1 was prioritised as a candidate gene, and 41 respiratory and cardiometabolic traits showed significant genetic correlations. Colocalisation, gene-prioritisation, and enrichment analyses identified candidate shared regions and highlighted extracellular-matrix, cell-adhesion, epithelial-barrier, and signalling-related annotations. Drug-target analyses showed pathway-level concordance with previously studied cardiopulmonary drug classes. These findings characterise shared genetic signals across the included traits and nominate candidates for functional follow-up. Because mvLung incorporates exposure-related and oxygenation phenotypes, the results do not represent direct genetic effects on pulmonary function alone, causal mechanisms, or therapeutic efficacy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genomic structural equation modeling uncovers shared genetic architecture and comorbidity mechanisms of lung function decline

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月20日

查看全文
  • Guanglei Chen,
  • Yunzhi Chen,
  • Cancan Chu,
  • Xing Zhu

摘要

Chronic respiratory diseases cause substantial global morbidity and mortality, yet the shared genetic architecture of pulmonary-function traits, exposure-related phenotypes, and cardiometabolic traits remains incompletely characterised. We applied genomic structural equation modelling to GWAS summary statistics for four pulmonary-function traits, lifetime smoking index, ambient PM2.5 exposure, and arterial oxygen tension to model their shared genetic covariance (mvLung). The mvLung GWAS identified 2,156 loci, including 376 not significant in the individual input GWASs. EFEMP1 was prioritised as a candidate gene, and 41 respiratory and cardiometabolic traits showed significant genetic correlations. Colocalisation, gene-prioritisation, and enrichment analyses identified candidate shared regions and highlighted extracellular-matrix, cell-adhesion, epithelial-barrier, and signalling-related annotations. Drug-target analyses showed pathway-level concordance with previously studied cardiopulmonary drug classes. These findings characterise shared genetic signals across the included traits and nominate candidates for functional follow-up. Because mvLung incorporates exposure-related and oxygenation phenotypes, the results do not represent direct genetic effects on pulmonary function alone, causal mechanisms, or therapeutic efficacy.